Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Dental management of patients on anti-thrombotic agents

  • Lee, Jeong Keun (Department of Oral and Maxillofacial Surgery and Institute of Oral Health Science, Ajou University Dental Hospital, Ajou University School of Medicine)
  • Received : 2018.07.10
  • Accepted : 2018.07.10
  • Published : 2018.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

The number of geriatric patients seeking dental service is ever-rising because of increased life expectancy, also with problem of increased chronic medical conditions. One of them are patients on anti-thrombotic medication. Bleeding complication after minor oral surgery by anti-thrombotic agents is of concerns to dentists on dental management of these patients. Risk and benefit of the anti-thrombotic agents must be weighed before initiating dental procedures, which should be established as a treatment guideline. Purpose of the paper is to optimize the management of the dental patients on antithrombotic medication via standardization of treatment protocol of such a patient.

Keywords

References

  1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS). Eur Heart J 2012;33:2451-96. https://doi.org/10.1093/eurheartj/ehs109
  2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Europace 2010;12:1360-420. https://doi.org/10.1093/europace/euq350
  3. Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg 2012;114:275-85. https://doi.org/10.1213/ANE.0b013e31823a088c
  4. Classification of antithrombotic agents [Internet]. Seoul: KIMS (Korean Index of Medical Specialties) [cited 2018 May 4]. Available from: http://www.kimsonline.co.kr/ResCenter/bookinbook/view/54.
  5. Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. Prostanoids and their receptor. In: Emmett JC, ed. Comprehensive medicinal chemistry: membranes and receptors. Oxford: Pergamon Press; 1990:643-714.
  6. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention. A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol 2011;58:e44-122. https://doi.org/10.1016/j.jacc.2011.08.007
  7. Lange RA, Hillis LD. The duel between dual antiplatelet therapies. N Engl J Med 2013;368:1356-7. https://doi.org/10.1056/NEJMe1302504
  8. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74. https://doi.org/10.1093/eurheartj/ehl334
  9. Oscarsson A, Gupta A, Fredrikson M, Jarhult J, Nystrom M, Pettersson E, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anesth 2010;104:305-12. https://doi.org/10.1093/bja/aeq003
  10. Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004;113:340-5. https://doi.org/10.1172/JCI20986
  11. Cattaneo M. Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution? J Thromb Haemost 2012;10:327-36. https://doi.org/10.1111/j.1538-7836.2011.04602.x
  12. de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 1994;269:15419-22.
  13. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009;119:2553-60. https://doi.org/10.1161/CIRCULATIONAHA.109.851949
  14. Birkeland K, Parra D, Rosenstein R. Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor. J Blood Med 2010;1:197-219.
  15. Davi G, Patrono C. Platelet activation and atherothrombosis. New Engl J Med 2007;357:2482-94. https://doi.org/10.1056/NEJMra071014
  16. Furie B, Furie BC. Mechanisms of thrombus formation. New Engl J Med 2008;359:938-49. https://doi.org/10.1056/NEJMra0801082
  17. de Souza Brito F, Tricoci P. Novel anti-platelet agents: focus on thrombin receptor antagonists. J Cardiovasc Transl Res 2013;6:415-24. https://doi.org/10.1007/s12265-013-9454-3
  18. Warfarin sodium [Internet]. Bethesda (MD): American Society of Health-System Pharmacists [cited 2018 Jun 6]. Available from: https://www.drugs.com/monograph/warfarin-sodium.html.
  19. Management of dental patients taking anticoagulants or antiplatelet drugs [Internet]. Dundee (Scotland): Scottish Dental Clinical Effectiveness Programme [cited 2018 Jun 6]. Available from: http://www.sdcep.org.uk/wp-content/uploads/2015/09/SDCEP-Anticoagulants-Guidance.pdf.
  20. Boehringer Ingelheim. Pradaxa 150 mg hard capsules [Internet]. Surrey (England): electronic Medicines Compendium (eMC) [cited 2018 May 22]. Available from: https://www.medicines.org.uk/emc/medicine/24839.
  21. Bayer plc. Xarelto 20 mg film-coated tablets [Internet]. Surrey (England): electronic Medicines Compendium (eMC) [cited 2018 May 22]. Available from: http://www.medicines.org.uk/emc/medicine/25586.
  22. Bristol-Myers Squibb-Pfizer. Eliquis 5 mg film-coated tablets [Internet]. Surrey (England): electronic Medicines Compendium (eMC) [cited 2018 May 22]. Available from: http://www.medicines. org.uk/emc/medicine/27220.
  23. Heart matters [Internet]. London: British Heart Foundation [cited 2018 Jun 6]. Available from: https://www.bhf.org.uk/heart-mattersmagazine/medical/drug-cabinet/novel-anticoagulants.
  24. Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015;373:511-20. https://doi.org/10.1056/NEJMoa1502000
  25. Blommel ML, Blommel AL. Dabigatran etexilate: a novel oral direct thrombin inhibitor. Am J Health Syst Pharm 2011;68:1506-19. https://doi.org/10.2146/ajhp100348
  26. Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013;369:1206-14. https://doi.org/10.1056/NEJMoa1300615
  27. Brown DG, Wilkerson EC, Love WE. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. J Am Acad Dermatol 2015;72:524-34. https://doi.org/10.1016/j.jaad.2014.10.027
  28. Armstrong MJ, Gronseth G, Anderson DC, Biller J, Cucchiara B, Dafer R, et al. Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the guideline development subcommittee of the American academy of neurology. Neurology 2013;80:2065-9. https://doi.org/10.1212/WNL.0b013e318294b32d
  29. Hsueh WD, Hwang PH, Abuzeid WM. Perioperative management of antithrombotic therapy in common otolaryngologic surgical procedures: state of the art review. Otolaryngol Head Neck Surg 2015;153:493-503. https://doi.org/10.1177/0194599815600409
  30. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. https://doi.org/10.1056/NEJMoa0905561
  31. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91. https://doi.org/10.1056/NEJMoa1009638
  32. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92. https://doi.org/10.1056/NEJMoa1107039
  33. Lockhart PB, Gibson J, Pond SH, Leitch J. Dental management considerations for the patient with an acquired coagulopathy. Part 1: coagulopathies from systemic disease. Br Dent J 2003;195:439-45. https://doi.org/10.1038/sj.bdj.4810593
  34. Chan FKL, Goh KL, Reddy N, Fujimoto K, Ho KY, Hokimoto S, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian pacific association of gastroenterology (APAGE) and Asian pacific society for digestive endoscopy (APSDE) practice guidelines. Gut 2018;67:405-17. https://doi.org/10.1136/gutjnl-2017-315131
  35. McCormick NJ, Moore UJ, Meechan JG. Haemostasis. Part 1: the management of post-extraction haemorrhage. Dent Update 2014;41:290-2, 294-6. https://doi.org/10.12968/denu.2014.41.4.290
  36. Surgical management of the primary care dental patient on antiplatelet medication [Internet]. Liverpool: North West Medicines Information Centre [cited 2018 Jun 4]. Available from: www.app.dundee.ac.uk/tuith/Static/info/antiplatelet.pdf.
  37. Napenas JJ, Oost FC, DeGroot A, Loven B, Hong CH, Brennan MT, et al. Review of postoperative bleeding risk in dental patients on antiplatelet therapy. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:491-9. https://doi.org/10.1016/j.oooo.2012.11.001
  38. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012;141(2 Suppl):e326S-50S. https://doi.org/10.1378/chest.11-2298
  39. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, et al. Antithrombotic therapy in atrial fibrillation: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133(6 Suppl):546S-92S. https://doi.org/10.1378/chest.08-0678
  40. Surgical management of the primary care dental patient on warfarin [Internet]. Liverpool: North West Medicines Information Centre [cited 2018 May 22]. Available from: http://www.app.dundee.ac.uk/tuith/Static/info/wafarin.pdf.
  41. Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc 2009;75:41.
  42. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary (BNF) 70. London: BMJ Group, Pharmaceutical Press; 2015.
  43. Favaloro EJ, Lippi G. The new oral anticoagulants and the future of haemostasis laboratory testing. Biochem Med (Zagreb) 2012;22:329-41.
  44. Scaglione F. New oral anticoagulants: comparative pharmacology with vitamin K antagonists. Clin Pharmacokinet 2013;52:69-82. https://doi.org/10.1007/s40262-012-0030-9
  45. Pfizer. Fragmin 10,000 IU/0.4ml solution for injection [Internet]. Surrey (England): electronic Medicines Compendium (eMC) [cited 2018 May 22]. Available from: http://www.medicines.org.uk/emc/medicine/26894.
  46. SANOFI. Clexane Forte Syringes [Internet]. Surrey (England): electronic Medicines Compendium (eMC) [cited 2018 May 22]. Available from: http://www.medicines.org.uk/emc/medicine/10054.

Cited by

  1. Classification of the journal category "oral surgery" in the Scopus and the Science Citation Index Expanded: flaws and suggestions vol.45, pp.4, 2018, https://doi.org/10.5125/jkaoms.2019.45.4.186
  2. Acute cardiovascular complications in patients with diabetes and hypertension: management consideration for minor oral surgery vol.45, pp.4, 2018, https://doi.org/10.5125/jkaoms.2019.45.4.207
  3. Oral Health-Related Quality of Life in Anticoagulated Patients with Warfarin Treatment: A Cross-Sectional Study vol.18, pp.7, 2021, https://doi.org/10.3390/ijerph18073714
  4. Kawasaki Disease and General Anesthesia for Dental Treatment: A Case Report vol.68, pp.3, 2018, https://doi.org/10.2344/anpr-68-01-06
  5. Analysing the effectiveness of topical bleeding care following tooth extraction in patients receiving dual antiplatelet therapy-retrospective observational study vol.21, pp.1, 2018, https://doi.org/10.1186/s12903-021-01391-9